Sun.Jan 21, 2024

article thumbnail

Inside the growing precision therapy market and the crucial role of pDNA manufacturing

Pharmaceutical Technology

CDMOs, who cater to the requirements of multiple companies and develop platform processes to achieve the much-needed economy of scale, are being seen as a possible solution.

article thumbnail

Disease X: WHO Warns Future Outbreak Just a Matter of Time

AuroBlog - Aurous Healthcare Clinical Trials blog

With a fatality rate 20 times that of COVID-19, and no vaccine, Disease X could swiftly bring humanity to its knees. Few would be left untouched by the pathogen were it to gain hold, causing healthcare systems to crumble and economies to collapse as the world once again tried to contain a force of nature.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BMS eyes first-line colorectal cancer use for Opdivo-Yervoy

pharmaphorum

Bristol-Myers Squibb’s Opdivo-Yervoy regimen improves PFS as first-line therapy for patients with MSI-H/dMMR colorectal cancer in CheckMate-8HW trial

Trials 100
article thumbnail

First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations

JAMA Internal Medicine

This cohort study compares the risk of congenital malformations among infants following in utero exposure to buprenorphine vs methadone.

59
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Pharma CEOs may be subpoenaed as IRA dispute rumbles on

pharmaphorum

A vote by the HELP committee in the US on 31st January could result in the CEOs of Johnson & Johnson and Merck being forced to testify on drug pricing

Drugs 77
article thumbnail

New patent expiration for Mayne Pharma drug RHOFADE

Drug Patent Watch

Annual Drug Patent Expirations for RHOFADE Rhofade is a drug marketed by Mayne Pharma and is included in one NDA. It is available from one supplier. There are eight patents… The post New patent expiration for Mayne Pharma drug RHOFADE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

Pharmaceutical companies with the most ‘New Patient Population’ drugs

Drug Patent Watch

This chart shows the companies which have received the most New Patient Population exclusivities in the past five years. New Patient Populations are one of the categories for which the… The post Pharmaceutical companies with the most ‘New Patient Population’ drugs appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 45